Nisa Investment Advisors’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $452 | Hold |
318
| – | – | ﹤0.01% | 2888 |
|
|
2025
Q1 | $487 | Hold |
318
| – | – | ﹤0.01% | 2802 |
|
|
2024
Q4 | $789 | Hold |
318
| – | – | ﹤0.01% | 2727 |
|
|
2024
Q3 | $366 | Sell |
318
-209
| -40% | -$241 | ﹤0.01% | 2772 |
|
|
2024
Q2 | $580 | Buy |
+527
| New | +$580 | ﹤0.01% | 2652 |
|
|
2023
Q4 | – | Sell |
-1,067
| Closed | -$7.31K | – | 2640 |
|
|
2023
Q3 | $7.31K | Sell |
1,067
-2,182
| -67% | -$14.9K | ﹤0.01% | 2230 |
|
|
2023
Q2 | $33.7K | Buy |
3,249
+2,802
| +627% | +$29.1K | ﹤0.01% | 1891 |
|
|
2023
Q1 | $4K | Sell |
447
-1,434
| -76% | -$12.8K | ﹤0.01% | 2252 |
|
|
2022
Q4 | $30K | Hold |
1,881
| – | – | ﹤0.01% | 1931 |
|
|
2022
Q3 | $29K | Buy |
1,881
+53
| +3% | +$817 | ﹤0.01% | 1936 |
|
|
2022
Q2 | $26K | Buy |
+1,828
| New | +$26K | ﹤0.01% | 1962 |
|